Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Common gene patterns may cause skin autoimmune diseases.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Alopecia areata is linked to autoimmune antibodies.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Monoclonal antibodies are often linked to alopecia areata cases.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Certain types of alopecia areata are linked to allergies, autoimmune diseases, and family history.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Managing multiple autoimmune diseases in one patient is very challenging.

Sex hormone antibodies can help identify male and female contributors in forensic samples.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Belimumab may cause hair loss in lupus patients.

The study identified key immune cell differences between mild and severe alopecia areata.